Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland
Robert Thomann,1 Stefan Zechmann,2 Nicola Alexander-David3,†, François R Jornayvaz4 1Bürgerspital Solothurn, Solothurn, Switzerland; 2Institute of Primary Care, University of Zurich, Zurich, Switzerland; 3Private Practice, Bellinzona, Switzerland; 4Hôpitaux U...
Guardado en:
Autores principales: | Thomann R, Zechmann S, Alexander-David N, Jornayvaz FR |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5a0f4f0a7b346c38eb61152ac5c83cc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
rDNA insulin glargine U300 – a critical appraisal
por: Wang F, et al.
Publicado: (2016) -
Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
por: Lau IT, et al.
Publicado: (2017) -
Effect of Adding Insulin Glargine on Glycemic Control in Critically Ill Patients Admitted to Intensive Care Units: A Prospective Randomized Controlled Study
por: Nader ND, et al.
Publicado: (2020) -
Association of Insulin Glargine Treatment with Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
por: Liu D, et al.
Publicado: (2021) -
On the safety of insulin Glargine
por: Ivan Ivanovich Dedov, et al.
Publicado: (2009)